Latest Financials News

Austal Limited reported a robust FY2025 with revenue up 24% and EBIT doubling, underpinned by a landmark Strategic Shipbuilding Agreement with the Australian Government and significant US contract wins.

DMC Mining Limited reports steady progress on its Guinea projects’ licences amid ongoing ASX re-admission efforts, despite critically low cash reserves.

Arafura Rare Earths has made decisive strides in funding its Nolans Project, securing up to US$400 million in conditional and indicative investments from Australian and US government-linked financiers, alongside a strong equity raise.

Arafura Rare Earths has launched a major A$475 million placement alongside a A$50 million share purchase plan, significantly advancing funding for its Nolans Project and edging closer to a Final Investment Decision in early 2026.

Macro Metals Limited has bolstered its financial position with a $2 million capital raise while making significant progress across its iron ore and construction sand projects, underpinned by strong Indigenous joint ventures and mining services development.

Klevo Rewards Limited reports a strong quarter with a tenfold increase in customer receipts and positive cash flow, completing a $3.4 million entitlement offer and advancing steps toward ASX reinstatement.

Assetora Limited has reopened its flagship fund under a new name, secured a $3 million strategic investment, and reported its first positive operating cashflow since adopting its fund-management model.

Carbonxt Group Limited has advanced its Kentucky activated carbon facility ownership to 45.9%, with kiln commissioning underway and a projected 200% sales increase. The company also raised $1.3 million to support growth amid strong regulatory demand for PFAS filtration products.

DMC Mining Group reported a modest cash outflow for the September quarter while securing a loan facility variation and initiating a $6 million capital raise to support its exploration ambitions.

Radiopharm Theranostics has secured FDA approval to initiate a Phase I trial targeting B7H3 and raised A$40 million to accelerate its radiopharmaceutical programs. The company also appointed renowned oncologist Dr Oliver Sartor to its Scientific Advisory Board.

Mount Burgess Mining has extinguished nearly $4.7 million in legacy debt and acquired promising gold projects in Western Australia, positioning itself for growth with a fresh capital raise and new board leadership.

Magontec Limited reports a 20.1% rise in gross profit to $9.3 million for the first nine months of 2025, driven by stronger magnesium alloy recycling and innovative electronic anode sales. The company also posts positive cashflow in Q3, signaling operational momentum.